The tree shrews: Useful animal models for the viral hepatitis and hepatocellular carcinoma

Hepato-Gastroenterology

Volumn 52, Issue 62, 2005, Pages 613-616

  Yang, Er Bin ^a   Cao, Ji ^b   Su, Jian Jia ^b   Chow, Pierce ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b Guangxi Cancer Institute   (China)

Author keywords

Aflatoxin B1; Hepatitis; Hepatitis B virus; Hepatocellular carcinoma; Tree shrews

Indexed keywords

AFLATOXIN B1; CARCINOGEN;

CANCER MODEL; CANCER RISK; CHIMPANZEE; DUCK; ENVIRONMENTAL EXPOSURE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS VIRUS; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; NONHUMAN; PRIMATE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SQUIRREL; VIRUS INFECTION; WOODCHUCK;

ANIMALS; CARCINOMA, HEPATOCELLULAR; DISEASE MODELS, ANIMAL; HEPATITIS B; LIVER NEOPLASMS, EXPERIMENTAL; TUPAIIDAE;

EID: 16344367247     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. El-Serag HB: Epidemiology of hepatocellular carcinoma. Clin Liver Dis 2001; 5:87-107.
2. Ross RK, Yuan JM, Yu MC, Wogan GN, Qian GS, Tu JT, Groopman JD, Gao YT, Henderson BE: Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 1992; 339:943-946.
3. Beasley RP: Hepatitis B virus, the major etiology of hepatocellular carcinoma. Cancer 1988; 61:1942-1956.
4. Fuchs E: Tree shrews. In: Poole T (Ed.). The UFAW Handbook on the Care and Management of Laboratory Animals. London: Blackwell Science, 1999; pp. 235-245.
5. Novacek MJ: Mammalian phylogeny: shaking the tree. Nature 1992; 356:121-125.
6. Edwards MH: Animal models of myopia. A review. Acta Ophthalmol Scand 1996; 74:213-219.
7. McBrien NA, Norton TT: Prevention of collagen crosslinking increases form-deprivation myopia in tree shrew. Exp Eye Res 1994; 59:475-486.
8. McBrien NA, Lawlor P, Gentle A: Scleral remodeling during the development of and recovery from axial myopia in the tree shrew. Invest Ophthalmol Vis Sci 2000; 41:3713-3719.
9. Phillips JR, Khalaj M, McBrien NA: Induced myopia associated with increased scleral creep in chick and tree shrew eyes. Invest Ophthalmol Vis Sci 2000; 41:2028-2034.
10. Fuchs E, Kramer M, Hermes B, Netter P, Hiemke C: Psychosocial stress in tree shrews: clomipramine counteracts behavioral and endocrine changes. Pharmacol Biochem Behav 1996; 54:219-228.
11. Flugge G: Alterations in the central nervous alpha 2-adrenoceptor system under chronic psychosocial stress. Neuroscience 1996; 75:187-196.
12. Flugge G: Dynamics of central nervous 5-HT1A-receptors under psychosocial stress. J Neurosci 1995; 15:7132-7140.
13. Alberti A, Diana S, Eddleston AL, Williams R: Changes in hepatitis B virus DNA polymerase in relation to the outcome of acute hepatitis type B. Gut 1979; 20:190-195.
14. Alberti A, Diana S, Scullard GH, Eddleston WF, Williams R: Full and empty Dane particles in chronic hepatitis B virus infection: relation to hepatitis B e antigen and presence of liver damage. Gastroenterology 1978; 75:869-874.
15. Blumberg BS, Larouze B, London WT, Werner B, Hesser JE, Millman I, Saimot G, Payet M: The relation of infection with the hepatitis B agent to primary hepatic carcinoma. Am J Pathol 1975; 81:669-682.
16. Blumberg BS, London WT: Hepatitis B virus: pathogenesis and prevention of primary cancer of the liver. Cancer 1982; 50:2657-2665.
17. Prince AM, Brotman B: Perspectives of hepatitis B studies with chimpanzees. ILAR J 2001; 42:85-88.
18. Summers J, Smolec JM, Snyder R: A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks. Proc Natl Acad Sci USA 1978; 75:4533-4537.
19. Tennant BC: Animal models of hepadnavirus-associated hepatocellular carcinoma. Clin Liver Dis 2001; 5:43-68.
20. Marion PL, Van Davelaar MJ, Knight SS, Salazar FH, Garcia G, Popper H, Robinson WS: Hepatocellurlar carcinoma in ground squirrels persistently infected with ground squirrel hepatitis virus. Proc Natl Acad Sci USA 1986; 83:4543-4546.
21. Cullen JM, Marion PL: Non-neoplastic liver disease associated with chronic ground squirrel hepatitis virus infection. Hepatology 1996; 23:1324-1329.
22. Cova L, Wild CP, Mehrotra R, Turusov V, Shirai T, Lambert V, Jacquet C, Tomatis L, Trepo C, Montesano R: Contribution of aflatoxin B1 and hepatitis B virus infection in the induction of liver tumors in ducks. Cancer Res 1990; 50:2156-2163.
23. Omata M, Uchiumi K, Ito Y, Yokosuka O, Mori J, Terao K, Wei-Fa Y, O'Connell AP, London WT, Okuda K: Duck hepatitis B virus and liver diseases. Gastroenterology 1983; 85:260-267.
24. Kim CM, Koike K, Saito I, Miyamura T, Jay G: HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991; 351:317-320.
25. Pasquinelli C, Bhavani K, Chisari FV: Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice. Cancer Res 1992; 52:2823-2829.
26. Walter E, Keist R, Niederost B, Pult I, Blum HE: Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Hepatology 1996; 24:1-5.
27. Yan RQ, Su JJ, Huang DR, Gan YC, Yang C, Huang GH: Human hepatitis B virus and hepatocellular carcinoma. I. Experimental infection of tree shrews with hepatitis B virus. J Cancer Res Clin Oncol 1996; 122:283-288.
28. Kock J, Nassal M, MacNelly S, Baumert TF, Blum HE, von Weizsacker F: Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus. J Virol 2001; 75:5084-5089.
29. Ren S and Nassal M: Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors. J Virol 2001; 75:1104-1116.
30. Zhao X, Tang ZY, Klumpp B, Wolff-Vorbeck G, Earth H, Levy S, von Weizsäcker F, Blum HE, Baumert TF: Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection. J Clin Invest 2002; 109:221-232.
31. Xie ZC, Riezu-Boj JI, Lasarte JJ, Guillen J, Su JH, Civeira MP and Prieto J: Transmission of hepatitis C virus infection to tree shrews. Virology 1998; 244:513-520.
32. Solt DB, Medline A, Farber E: Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis. Am J Pathol 1977; 88:595-618.
33. Morris HP, Slaughter LJ: Development, growth rate, degree of malignancy, and chromosome pattern of Morris transplantable hepatomas. J Toxicol Environ Health 1979; 5:433-452.
34. Yang EB, Tang WY, Zhang K, Cheng LY, Mack PO: Norcantharidin inhibits growth of human HepG2 cell-transplanted tumor in nude mice and prolongs host survival. Cancer Lett 1997; 117:93-98.
35. Yan RQ, Su JJ, Huang DR, Can YC, Yang C, Huang GH: Human hepatitis B virus and hepatocellular carcinoma. II. Experimental induction of hepatocellular carcinoma in tree shrews exposed to hepatitis B virus and aflatoxin B1. J Cancer Res Clin Oncol 1996, 122:289-295.
36. Su JJ, Qin GZ, Yan RQ, Huang DR, Yang C, Lotlikar PD: The expression of insulin-like growth factor II, hepatitis B virus X antigen and p21 in experimental hepatocarcinogenesis in tree shrews. Ann Acad Med Singapore 1999; 28:62-66.
37. Park US, Su JJ, Ban KC, Qin L, Lee EH, Lee YI: Mutations in the p53 tumor suppressor gene in tree shrew hepatocellular carcinoma associated with hepatitis B virus infection and intake of aflatoxin B1. Gene 2000; 251:73-80.
38. Li Y, Su J, Qin L, Egner PA, Wang J, Groopman JD, Kensler TW, Roebuck BD: Reduction of aflatoxin B(1) adduct biomarkers by oltipraz in the tree shrew (Tupaia)